This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: British Biotech Pharmaceuticals Limited, British Bio-Technology Limited. Active years: 1993-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Marlow, GB (1993 - 1997)
- Oxford, GB (1997 - 1999)
- Cowley, GB (1997 - 1999)
Company Filing History:
5 out of 85 
3 out of 25 Years Active: 1993-1999
Title: The Inventive Journey of Keith Martyn Dawson
Introduction:
Keith Martyn Dawson, a prolific inventor based in Oxford, GB, has made significant contributions in the field of biotechnology with a total of 8 patents to his name.
Latest Patents:
1. Disaggregated mutant human RANTES: Dawson's innovation focuses on mutants of human RANTES that exhibit reduced aggregation into large multimeric complexes, leading to lower pro-inflammatory responses compared to the wild-type molecule.
2. Modified plasmin precursors with resistance to inhibitors of plasmin: He has modified plasmin precursors to resist inhibitors, enhancing their fibrinolytic, thrombolytic, or antithrombotic properties for the treatment of blood clotting disorders.
Career Highlights:
Dawson has worked with renowned companies such as British Biotech Pharmaceuticals Limited and British Biotechnology Limited, driving innovation and research in the biotech industry.
Collaborations:
During his career, Dawson collaborated with esteemed coworkers like Michael George Hunter and Richard Mark Edwards, pooling their expertise to bring groundbreaking inventions to life.
Conclusion:
Keith Martyn Dawson's inventive spirit and dedication to advancing biotechnology have left a lasting impact on the industry, with his patents paving the way for new developments in medical treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile